Bunnage Mark E.
EVP, Chief Scientific Officer · 10 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 33 | $453.45 | $14,963.85 | filing |
| 2026-02-25 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 620 | $486.35 | $301,537.00 | filing |
| 2026-02-24 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Tax withholding | 582 | $485.11 | $282,334.02 | filing |
| 2026-02-18 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 1,182 | $473.68 | $559,889.76 | filing |
| 2026-02-17 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 2,437 | $489.46 | $1.2M | filing |
| 2026-02-17 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Tax withholding | 1,110 | $483.75 | $536,962.50 | filing |
| 2026-02-17 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Award | 2,584 | $0.00 | $0.00 | filing |
| 2026-02-13 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Tax withholding | 2,283 | $487.76 | $1.1M | filing |
| 2026-02-11 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 2,021 | $460.43 | $930,529.03 | filing |
| 2026-02-10 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Tax withholding | 1,127 | $468.41 | $527,898.07 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.